Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
This study is ongoing, but not recruiting participants.
Study NCT00159250   Information provided by Imperial College London
First Received: September 8, 2005   Last Updated: July 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Duchenne Muscular Dystrophy
Additional conditions recognized in this trial
Muscular Dystrophies
Muscular Dystrophy, Duchenne
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Interventions listed in this trial
AVI-4658 (PMO)
Sponsors listed in this trial
Imperial College London
Department of Health


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services